Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (181-190 of 400) with videos related to

Pageof 40
Sort By:
International Journal of Molecular Imaging|July 15, 2011
Functional Imaging of Pheochromocytoma with Ga-DOTATOC and C-HED in a Genetically Defined Rat Model of Multiple Endocrine NeoplasiaMatthias Miederer, Sara Molatore, Ilaria Marinoni, et al.
Clinical Nuclear Medicine|July 6, 2019
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple MyelomaConstantin Lapa, Malte Kircher, Matteo Da Via, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 31, 2004
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?G Halter, A K Buck, H Schirrmeister, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Hexokinase-2 Expression in <sup>11</sup>C-Methionine-Positive, <sup>18</sup>F-FDG-Negative Multiple MyelomaStefan Kircher, Antje Stolzenburg, Klaus Martin Kortüm, et al.
BMJ Open|November 17, 2025
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiformeJohannes Pärtel Truusalu, Kersti Oselin, Jana Lass, et al.
The Journal of Surgical Research|August 6, 2025
Opioid Use Within a Year Following Discharge in Trauma Patients With Prior Opioid Use DisorderHannah Bard, Samantha Watts, Gurkeerat Singh, et al.
Theranostics|February 16, 2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow InvolvementConstantin Lapa, Stefan Knop, Martin Schreder, et al.
Cancers|June 10, 2022
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission TomographyAleksander Kosmala, Sebastian E Serfling, Niklas Dreher, et al.
The Pediatric Infectious Disease Journal|June 1, 1995
Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trialJ S Garland, R K Buck, P Maloney, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CTStefan Krüger, Andreas K Buck, Felix M Mottaghy, et al.
Pageof 40

Showing results (181-190 of 400) with videos related to

Sort By:
Pageof 40
International Journal of Molecular Imaging|July 15, 2011
Functional Imaging of Pheochromocytoma with Ga-DOTATOC and C-HED in a Genetically Defined Rat Model of Multiple Endocrine NeoplasiaMatthias Miederer, Sara Molatore, Ilaria Marinoni, et al.
Clinical Nuclear Medicine|July 6, 2019
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple MyelomaConstantin Lapa, Malte Kircher, Matteo Da Via, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 31, 2004
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?G Halter, A K Buck, H Schirrmeister, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Hexokinase-2 Expression in <sup>11</sup>C-Methionine-Positive, <sup>18</sup>F-FDG-Negative Multiple MyelomaStefan Kircher, Antje Stolzenburg, Klaus Martin Kortüm, et al.
BMJ Open|November 17, 2025
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiformeJohannes Pärtel Truusalu, Kersti Oselin, Jana Lass, et al.
The Journal of Surgical Research|August 6, 2025
Opioid Use Within a Year Following Discharge in Trauma Patients With Prior Opioid Use DisorderHannah Bard, Samantha Watts, Gurkeerat Singh, et al.
Theranostics|February 16, 2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow InvolvementConstantin Lapa, Stefan Knop, Martin Schreder, et al.
Cancers|June 10, 2022
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission TomographyAleksander Kosmala, Sebastian E Serfling, Niklas Dreher, et al.
The Pediatric Infectious Disease Journal|June 1, 1995
Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trialJ S Garland, R K Buck, P Maloney, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CTStefan Krüger, Andreas K Buck, Felix M Mottaghy, et al.
Pageof 40